KORU Medical Systems, Inc. (KRMD)
USD 2.06
(-3.74%)
USD 2.06
(-3.74%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 3.65 Million USD | -9.75% |
| 2022 | 4.04 Million USD | 0.0% |
| 2021 | - USD | -100.0% |
| 2020 | 95.55 Thousand USD | -60.1% |
| 2019 | 239.49 Thousand USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | -100.0% |
| 2012 | 393.86 Thousand USD | -10.34% |
| 2011 | 439.3 Thousand USD | 12267.85% |
| 2010 | 3552.00 USD | -99.43% |
| 2009 | 623.73 Thousand USD | -8.64% |
| 2008 | 682.72 Thousand USD | 60.17% |
| 2007 | 426.25 Thousand USD | -50.15% |
| 2006 | 855 Thousand USD | 61.13% |
| 2005 | 530.61 Thousand USD | 15.26% |
| 2004 | 460.38 Thousand USD | 22.82% |
| 2003 | 374.84 Thousand USD | 189.2% |
| 2002 | 129.61 Thousand USD | 135.24% |
| 2001 | 55.09 Thousand USD | 112.57% |
| 2000 | 25.92 Thousand USD | 0.0% |
| 1999 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 3.46 Million USD | 0.0% |
| 2024 Q1 | 3.53 Million USD | 0.0% |
| 2023 Q1 | 3.93 Million USD | -2.82% |
| 2023 Q3 | 3.7 Million USD | -3.05% |
| 2023 Q2 | 3.81 Million USD | -2.93% |
| 2023 FY | 3.65 Million USD | -9.75% |
| 2023 Q4 | 3.65 Million USD | -1.31% |
| 2022 Q3 | 4 Million USD | -2.51% |
| 2022 FY | 4.04 Million USD | 0.0% |
| 2022 Q4 | 4.04 Million USD | 1.02% |
| 2022 Q1 | 3.91 Million USD | 0.0% |
| 2022 Q2 | 4.1 Million USD | 5.01% |
| 2021 Q1 | 59.72 Thousand USD | -37.49% |
| 2021 Q2 | 24.03 Thousand USD | -59.76% |
| 2021 Q4 | - USD | 0.0% |
| 2021 Q3 | - USD | -100.0% |
| 2021 FY | - USD | -100.0% |
| 2020 Q3 | 131.64 Thousand USD | -21.41% |
| 2020 Q2 | 167.51 Thousand USD | -17.66% |
| 2020 Q4 | 95.55 Thousand USD | -27.42% |
| 2020 FY | 95.55 Thousand USD | -60.1% |
| 2020 Q1 | 203.44 Thousand USD | -15.05% |
| 2019 Q1 | 341.47 Thousand USD | 0.0% |
| 2019 Q3 | 271.67 Thousand USD | -11.32% |
| 2019 Q4 | 239.49 Thousand USD | -11.85% |
| 2019 FY | 239.49 Thousand USD | 0.0% |
| 2019 Q2 | 306.36 Thousand USD | -10.28% |
| 2018 Q1 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2013 FY | - USD | -100.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q2 | - USD | -100.0% |
| 2013 Q1 | 393.86 Thousand USD | -2.77% |
| 2012 Q1 | 439.3 Thousand USD | -2.47% |
| 2012 Q3 | 375.00 USD | -99.91% |
| 2012 FY | 393.86 Thousand USD | -10.34% |
| 2012 Q2 | 428.01 Thousand USD | -2.57% |
| 2012 Q4 | 405.1 Thousand USD | 107927.2% |
| 2011 Q4 | 450.42 Thousand USD | -2.37% |
| 2011 FY | 439.3 Thousand USD | 12267.85% |
| 2011 Q2 | 472.17 Thousand USD | 13193.13% |
| 2011 Q1 | 3552.00 USD | -99.28% |
| 2011 Q3 | 461.38 Thousand USD | -2.29% |
| 2010 Q1 | 623.73 Thousand USD | -5.15% |
| 2010 FY | 3552.00 USD | -99.43% |
| 2010 Q4 | 493.26 Thousand USD | -2.05% |
| 2010 Q3 | 503.58 Thousand USD | -1.98% |
| 2010 Q2 | 513.73 Thousand USD | -17.64% |
| 2009 Q3 | 665.06 Thousand USD | -1.11% |
| 2009 Q4 | 657.61 Thousand USD | -1.12% |
| 2009 FY | 623.73 Thousand USD | -8.64% |
| 2009 Q1 | 682.72 Thousand USD | 61.44% |
| 2009 Q2 | 672.51 Thousand USD | -1.5% |
| 2008 Q3 | 424.14 Thousand USD | -0.33% |
| 2008 FY | 682.72 Thousand USD | 60.17% |
| 2008 Q4 | 422.89 Thousand USD | -0.29% |
| 2008 Q2 | 425.54 Thousand USD | -0.17% |
| 2008 Q1 | 426.25 Thousand USD | -50.15% |
| 2007 FY | 426.25 Thousand USD | -50.15% |
| 2007 Q4 | 855 Thousand USD | 0.0% |
| 2007 Q3 | 855 Thousand USD | 0.0% |
| 2007 Q2 | 855 Thousand USD | 0.0% |
| 2007 Q1 | 855 Thousand USD | 0.0% |
| 2006 Q4 | 855 Thousand USD | -5.52% |
| 2006 Q1 | 530.61 Thousand USD | 1.07% |
| 2006 FY | 855 Thousand USD | 61.13% |
| 2006 Q2 | 530 Thousand USD | -0.12% |
| 2006 Q3 | 905 Thousand USD | 70.75% |
| 2005 Q3 | 531.76 Thousand USD | -0.72% |
| 2005 Q2 | 535.61 Thousand USD | 16.34% |
| 2005 Q1 | 460.38 Thousand USD | -0.63% |
| 2005 Q4 | 525 Thousand USD | -1.27% |
| 2005 FY | 530.61 Thousand USD | 15.26% |
| 2004 Q2 | 470.78 Thousand USD | 25.59% |
| 2004 Q1 | 374.84 Thousand USD | 1554.51% |
| 2004 FY | 460.38 Thousand USD | 22.82% |
| 2004 Q4 | 463.3 Thousand USD | -0.97% |
| 2004 Q3 | 467.86 Thousand USD | -0.62% |
| 2003 Q2 | 36.6 Thousand USD | -71.76% |
| 2003 Q1 | 129.61 Thousand USD | 0.0% |
| 2003 Q4 | 22.65 Thousand USD | -22.18% |
| 2003 Q3 | 29.11 Thousand USD | -20.46% |
| 2003 FY | 374.84 Thousand USD | 189.2% |
| 2002 Q1 | 55.09 Thousand USD | -6.16% |
| 2002 Q2 | 61.85 Thousand USD | 12.27% |
| 2002 Q3 | 55.94 Thousand USD | -9.56% |
| 2002 Q4 | - USD | -100.0% |
| 2002 FY | 129.61 Thousand USD | 135.24% |
| 2001 Q2 | 22.21 Thousand USD | -14.29% |
| 2001 Q3 | 46.16 Thousand USD | 107.79% |
| 2001 Q4 | 58.71 Thousand USD | 27.19% |
| 2001 Q1 | 25.92 Thousand USD | -6.67% |
| 2001 FY | 55.09 Thousand USD | 112.57% |
| 2000 Q4 | 27.77 Thousand USD | 0.0% |
| 2000 FY | 25.92 Thousand USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 75.25 Million USD | 95.146% |
| AngioDynamics, Inc. | 3.93 Million USD | 7.263% |
| AtriCure, Inc. | 60.59 Million USD | 93.971% |
| Avinger, Inc. | - USD | -Infinity% |
| Azenta, Inc. | 60.43 Million USD | 93.956% |
| BioLife Solutions, Inc. | 18.31 Million USD | 80.051% |
| The Cooper Companies, Inc. | 2.52 Billion USD | 99.855% |
| Daxor Corporation | 755.65 Thousand USD | -383.409% |
| Ekso Bionics Holdings, Inc. | 4.83 Million USD | 24.401% |
| Femasys Inc. | 4.25 Million USD | 14.214% |
| GlucoTrack, Inc. | 196 Thousand USD | -1763.736% |
| Harvard Bioscience, Inc. | 30.7 Million USD | 88.103% |
| Hologic, Inc. | 2.49 Billion USD | 99.854% |
| ICU Medical, Inc. | 1.57 Billion USD | 99.768% |
| Intuitive Surgical, Inc. | -82.1 Million USD | 104.449% |
| LeMaitre Vascular, Inc. | 16.62 Million USD | 78.026% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Masimo Corporation | 871.7 Million USD | 99.581% |
| Microbot Medical Inc. | 40 Thousand USD | -9032.308% |
| Meihua International Medical Technologies Co., Ltd. | 4592.00 USD | -79449.717% |
| Merit Medical Systems, Inc. | 823.01 Million USD | 99.556% |
| Nephros, Inc. | 1.39 Million USD | -162.8% |
| NovoCure Limited | 596.24 Million USD | 99.387% |
| NEXGEL, Inc. | 513 Thousand USD | -612.071% |
| NEXGEL, Inc. | 513 Thousand USD | -612.071% |
| Singular Genomics Systems, Inc. | 67.52 Million USD | 94.59% |
| OraSure Technologies, Inc. | 11.38 Million USD | 67.923% |
| Pro-Dex, Inc. | 7.53 Million USD | 51.527% |
| Pulse Biosciences, Inc. | 8.08 Million USD | 54.824% |
| Predictive Oncology Inc. | 2.18 Million USD | -66.878% |
| Precision Optics Corporation, Inc. | 1.93 Million USD | -88.492% |
| QuidelOrtho Corporation | 2.27 Billion USD | 99.839% |
| Repligen Corporation | 510.14 Million USD | 99.284% |
| Sanara MedTech Inc. | 9.11 Million USD | 59.916% |
| STAAR Surgical Company | 31.46 Million USD | 88.391% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 295 Thousand USD | -1138.279% |
| DENTSPLY SIRONA Inc. | 1.79 Billion USD | 99.797% |
| Jin Medical International Ltd. | - USD | -Infinity% |